|
.
Jerry Avorn, M.D., is Professor of Medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. An internist, he has worked as a primary care physician and geriatrician and has been studying drug use and its outcomes for over 25 years.
Niteesh Choudhry, M.D., Ph.D., is an Assistant Professor of Medicine at Harvard Medical School and a Hospitalist at Brigham and Women's Hospital whose research focuses on the use of medications to treat common chronic conditions.
Michael Fischer, M.D., M.S., is a primary care internist and Instructor in Medicine at Harvard who studies cost-effective drug use in outpatient practices.
Frank May, M.App.Sci., is a Visiting Clinical Professor of Medicine at Harvard with research interests in educational communication and translation of biomedical knowledge into clinical practice.
Sebastian Schneeweiss, M.D., Sc.D., is an Associate Professor of Medicine at Harvard whose research focuses on the clinical and economic consequences of prescribing.
Will Shrank, M.D., M.S., is an Instructor in Medicine at Harvard, general internist, and primary care physician who studies patient compliance with medications.
Daniel Solomon, M.D., M.P.H., is an Assistant Professor of Medicine at Harvard and a rheumatologist specializing in the effects of NSAIDs and drugs for osteoporosis.
Michelle Spetman, M.S., M.P.H., is the project manager of the Independent Drug Information Service. Her research interests focus on the ways in which policies, incentives, and education impact health behavior and outcomes.
|
